Cisplatin chemotherapy and surgery are effective treatments for children with standard-risk hepatoblastoma but may cause considerable and irreversible hearing loss. This trial compared cisplatin with ...

Vials of drug Currently, there is no approved therapy for calciphylaxis. Intravenous sodium thiosulfate does not improve skin lesions or reduce the risk of dying from calciphylaxis, a rare but ...

Please provide your email address to receive an email when new articles are posted on . AUSTIN, Texas — Use of sodium thiosulfate to treat calciphylaxis in patients on peritoneal dialysis can be ...

Thiosulfate leaching is emerging as a promising alternative to traditional cyanidation methods in gold extraction. This process utilises thiosulfate as a lixiviant, offering enhanced environmental ...

The US Food and Drug Administration (FDA) has approved sodium thiosulfate (Pedmark, Fennec Pharmaceuticals) injection to reduce the risk for ototoxicity associated with cisplatin in pediatric patients ...

There is a simple discount patient access scheme for anhydrous sodium thiosulfate. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can ...

Prognostic and Predictive Value of Immunoscore in Stage III Colorectal Cancer: Pooled Analysis of Cases From the SCOT and IDEA-HORG Studies Hearing loss occurs in 50%-70% of children treated with ...

The evaluation committee considered evidence submitted by Norgine, a review of this submission by the external assessment group (EAG), and responses from stakeholders. See the committee papers for ...